TYO:4564

OncoTherapy Science,Inc. Stock Insider Trading

Tokyo Stock Exchange > Healthcare > Biotechnology

Open Broker Account

JP¥18.00

+1.00 (+5.88%)

At Close: May 01, 2024

There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:

Sorry! Image not available at this moment

About OncoTherapy Science,Inc.

OncoTherapy Science, Inc. researches and develops anti-cancer medicines and therapies in Japan. Its clinical development product pipeline includes small-molecule drugs, such as OTS167, a maternal embryonic leucine zipper kinase inhibitor that is in Phase I/II clinical trials for the treatment of acute myeloid leukemia, as well as in Phase I clinical trials for the treatment of breast cancer; and OTS964, a T-LAK cell-originated protein kinase inhi... 4564.T Profile

Golden Star

Ticker	Date	Change	Price
HRB	Apr 29	1.00%	$47.23
LYG	Apr 29	0.391%	$2.56
ORA	Apr 29	1.95%	$64.48
ETSY	Apr 26	3.43%	$67.43
DHT	Apr 24	0.98%	$11.28
LPLA	Apr 19	1.10%	$262.59
MLI	Apr 19	7.29%	$52.28
PFLT	Apr 18	1.33%	$11.25
DOOR	Apr 18	0.94%	$131.39
OCSL	Apr 17	0.360%	$19.43

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In

OncoTherapy Science,Inc. Stock Insider Trading

About OncoTherapy Science,Inc.

Golden Star

Top Fintech Company